More people seeing doctors less due to costs
LEHI, Utah More than half of consumers are seeing their doctors less, according to a new poll released Tuesday by checkMD. And nearly 24 percent felt that their employer did not provide adequate healthcare coverage and 14 percent are getting no healthcare coverage from their employer at all.
The poll of 274 participants results correspond with recent studies showing that out-of-pocket spending on healthcare for insured consumers has more than doubled in the last five years, in part to help pay for the care of the 46 million uninsured Americans. “These numbers, while shocking, underscore the complexities of today’s healthcare landscape and the challenges that the next administration will face,” stated Jon Black, chief executive officer of checkMD. “With climbing healthcare costs and challenging economic times, Americans are under more pressure to carefully evaluate providers to make informed choices.”
FDA grants conditional approval to generic version of Wyeth’s Effexor
PITTSBURGH The Food and Drug Administration has given tentative approval to a generic version of Wyeth Pharmaceutical’s Effexor XR, an antidepressant.
Mylan announced the FDA decision Monday for its version of the drug, known generically as venlafaxine hydrochloride. Mylan plans to sell the extended-release capsules in 37.5 mg, 75 mg and 150 mg formulations.
The branded version of the drug had sales of $3 billion during the 12 months ending Sept. 30, according to IMS Health.
Interpol seizes more than $6 million in counterfeit prescription drugs in Asia
NEW YORK More than $6 million in counterfeit drugs were seized in an international Interpol sting as part of an investigation lasting five months.
The bust, called Operation Storm, netted $6.65 million in counterfeits of drugs for malaria, HIV and tuberculosis in Singapore, Myanmar, Vietnam, Thailand, Laos, Cambodia and China.
The international law-enforcement agency arrested 27 people in the sting.